Emergent BioSolutions Inc.EBSNYSE
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank93
5Y CAGR-6.7%
Studio
Year-over-Year Change

Year-over-year operating income growth rate

5Y CAGR
-6.7%/yr
Long-term compound
Percentile
P93
Near historical high
vs 5Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
2025201.38%
202485.04%
2023-327.29%
2022-149.79%
2021-22.14%
2020284.31%
201927.06%
2018-27.76%
201717.82%
2016-25.45%